Marcus Deschauer

Marcus Deschauer

Auto-generated profile, based on publicly available information

Marcus Deschauer

Department of Neurology, TUM University Hospital – Klinikum rechts der Isar, TUM School of Medicine, Technical University of Munich, Munich 81675, Germany

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2005 in Archives of Neurology
Verified
Journal Article
Open access
PDF file
MDMarcus Deschauer
Marcus Deschauer
TWThomas Wieser
Thomas Wieser
SZStephan Zierz
Stephan Zierz
Review from JAMA Neurology — Muscle Carnitine Palmitoyltransferase II Deficiency — Clinical and Molecular Genetic Features and Diagnostic Aspects

1 January 2013 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
Maggie WalterMaggie Walter
Maggie Walter
PRPeter Reilich
Peter Reilich
STSimone Thiele
Simone Thiele
JSJoachim Schessl
Joachim Schessl
HSHerbert Schreiber
Herbert Schreiber
HLHanns Lochmüller
Hanns Lochmüller
Dysferlinopathies are autosomal recessive disorders caused by mutations in the dysferlin (DYSF) gene encoding the dysferlin protein. DYSF mutations lead to a wide range of muscular phenotypes, with the most prominent being Miyoshi myopathy (MM) and limb girdle muscular dystrophy type 2B (LGMD2B).

1 April 2005 in Neuromuscular Disorders
Verified
Journal Article
Closed access
MDMarcus Deschauer
Marcus Deschauer
GHGavin Hudson
Gavin Hudson
TMTobias Müller
Tobias Müller
RTRobert W. Taylor
Robert W. Taylor
PCPatrick F. Chinnery
Patrick F. Chinnery
SZStephan Zierz
Stephan Zierz

15 May 2012 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
MDM. Deschauer
M. Deschauer
CGC. Gaul
C. Gaul
CBC. Behrmann
C. Behrmann
PHProkisch Holger
Prokisch Holger
SZS. Zierz
S. Zierz
THT. B. Haack
T. B. Haack

1 November 2001 in Archives of Neurology
Verified
Journal Article
Open access
PDF file
MDMarcus Deschauer
Marcus Deschauer
TMTobias Müller
Tobias Müller
TWThomas Wieser
Thomas Wieser
WSWilhelm Schulte-Mattler
Wilhelm Schulte-Mattler
MKMalte Kornhuber
Malte Kornhuber
SZStephan Zierz
Stephan Zierz
THE MITOCHONDRIAL DNA transfer RNALeu(UUR) A3243G mutation was first described in patients with MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes) syndrome in 1990 by Goto et al.1 During the past 10 years, numerous other phenotypes of the A3243G mutation have been reported: chronic progressive external ophthalmoplegia,2 diabetes mellitus and deafness,3 cardiomyopathy,4 painful muscle stiffness,5 MERRF (myoclonic epilepsy with ragged-red fibers) syndrome,6 and dystonia.7 The A3243G mutation is regarded as the most frequent mitochondrial point mutation. In a Finnish population, prevalence was estimated to be greater than 16 in 100 000.8

11 December 2021 in Rheumatology
Verified
Journal Article
Open access
ICIsabell Cordts
Isabell Cordts
JHJudith S Hecker
Judith S Hecker
DGDarja Gauck
Darja Gauck
JPJoohyun Park
Joohyun Park
JHJohanna Härtl
Johanna Härtl
BHBernhard Hemmer
Bernhard Hemmer